ECP
AGN

Empyrean Capital Partners’s Allergan Inc AGN Stock Holding History

Empyrean Capital Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-500,000
Closed -$84.6M – 73
2014
Q2 		$84.6M Buy
+500,000
New +$77.8M 2.98% 8

Other funds holding AGN

PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Empyrean Capital Partners's AGN Position: Q3 2014 in Review

Empyrean Capital Partners sold out of Allergan Inc (AGN) in Q3 2014, closing a stake of 500,000 shares — an estimated $84.6M sold.

Empyrean Capital Partners first reported a position in AGN in Q2 2014 and held it in 1 quarter. The position peaked at $84.6M in Q2 2014. 749 funds tracked by Wall St. Rank hold AGN as of Q3 2014.

  • Empyrean Capital Partners reported no remaining Allergan Inc position as of Q3 2014 after selling out during the quarter.
  • Empyrean Capital Partners sold 500,000 Allergan Inc shares in Q3 2014, an estimated $84.6M.
  • Empyrean Capital Partners first reported a position in Allergan Inc in Q2 2014 and held it in 1 quarter.
  • Empyrean Capital Partners's Allergan Inc position peaked at $84.6M in Q2 2014.
  • 749 funds tracked by Wall St. Rank held Allergan Inc as of Q3 2014.

Based on Empyrean Capital Partners's 13F filing for Q3 2014, filed 14 Nov 2014.